HPLC studies in hemoglobinopathies
Tóm tắt
An accurate diagnosis of β-thalassemia carriers, homozygous patients and identification of different structural hemoglobin variants is important for epidemiological studies as well as for management and prevention of the major hemoglobin disorders. There are many electrophoretic and chromatographic approaches for estimation of HbA2 and Hb F but cation exchange HPLC (CE-HPLC)using automated dedicated machines like the Variant Hb testing system have become the method of choice for these investigations. CE-HPLC also helps in the presumptive identification of many abnormal hemoglobin variants and has been useful for both neonatal screening of sickle cell disease as well as second trimester prenatal diagnosis of thalassemia by fetal blood analysis. Other applications of HPLC in hemoglobinopathies include separation of globin chains, measuring the ratio of gamma globin chains (Gγ/Aγ) and the recently described denaturing HPLC for detecting mutations in both α and β globin genes.
Tài liệu tham khảo
Weatherall DJ, Clegg JB. The Thalassemia Syndromes. Oxford, Blackwell Science, 2001.
Sood SK, Madan N, Colah R, Sharma S, Apte SV eds Collaborative Study on thalassemia — An ICMR Task Force Study, New Delhi. Indian Council of Medical Research 1993.
Desai SN, Colah RB. Alpha thalassemia syndromes in India. Ind J Hum Genet 1997; 3: 1–9.
Clarke GM, Higgins TN. Laboratory investigations of hemoglobinopathies and thalassemias: Review and update. Clin Chem 2000; 46: 1284–1290.
Wild BJ, Bain BJ. Investigation of abnormal hemoglobins and thalassemia. In Lewis SM, Bain BJ, Bates I, eds. Dacie & Lewis Practical Hematology. 9th ed. Churchill Livingstone 2001; 231–268.
George E, Khoo SK, Mukhtar AB, Nor Aini U. Screening for thalassemia in pregnant women: A laboratory perspective. Malaysian J Med & Health Sciences 2005; 1: 111–117.
Working Party of the General Hematology Task Force of the British Committee for Standards in Hematology. Guideline: The laboratory diagnosis of hemoglobinopathies. Brit J Hematol 1998; 101: 783–792.
Jones W and Clark LA. Hemoglobinopathy and thalassemia testing: An automated method. Amer. Clin. Lab. Nov 1994.
Bain BJ. Hemoglobinopathy diagnosis. England; Oxford, Blackwell Science Ltd, 2001; 260.
Wajcman H, Prehu C, Bardakdijian-Michau J, Prome D, Riou J, Godart C, Mathis M, Hurtrel D, Galacteros F. Abnormal hemoglobins: Laboratory methods. Hemoglobin 2001; 25: 169–181.
Mario N, Baudin B, Aussel C, Giboudeau J. Capillary IEF and HPLC compared for the qualitative and quantitative analysis of hemoglobin variants. Clin Chem 1997; 43: 2137–2142.
Suh DD, Kruss JS, Bures K. Influence of Hb S adducts on HbA2 quantitation by HPLC. Clin Chem 1996; 42: 113–114.
Cotton F, Gulbis B, Hansen V, Vertongen F. Interference of Hb D in HbA2 measurement by cation exchange HPLC. Clin Chem 1999; 45: 1317–1318.
Joutovsky A, Hadzi-Nesic J, Nardi MA. Retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: A study of 60,000 samples in a clinical diagnostic laboratory. Clin Chem 2004; 50: 1736–1747.
Colah RB, Wadia M, Surve R, Nadkarni A, Phanasgaonkar S, Gorakshakar A, Mohanty D, Prome D, Wajcman H. Hb D Agri [β9 (A6) Ser → Tyr, β 121 (GH − 4) Glu → Gln]: A new Indian hemoglobin variant with two amino acid substitutions in the same beta chain. Hemoglobin 2001; 25: 317–321.
Wajcman H, Riou J, Yapo AP. Globin chain analysis by reversed phase high performance liquid chromatography: Recent developments. Hemoglobin 2002; 26: 271–284.
Henthorn JS, Almeida AM, Davies SC. Neonatal screening for sickle cell disorders. Brit J Hematol 2004; 124: 259–263.
Campbell M, Henthorn JS, Davies SC. Evaluation of cation exchange HPLC compared with isoelectric focusing for neonatal hemoglobinopathy screening. Clin Chem 1999; 45: 969–975.
Panadea C, Eckman JR, Kuchnert RS, Platt AF. Comparison of liquid and dried blood for neonatal hemoglobin screening: Laboratory and programmatic issues. Pediatrics 1994; 93: 427–432.
Angastiniotis M, Modell B, Boulinzhenkov V. Prevention and control of hemoglobinopathies. Bull WHO 1995; 73: 375–386.
Samawat A, Modell B. Iranian national thalassemia screening programme. Brit Med J 2004; 329: 1134–1137.
Wadia MR, Phanasgaonkar SP, Nadkarni AH, Surve RR, Gorakshakar AC, Colah RB, Mohanty D. Usefulness of automated chromatography for rapid fetal blood analysis for second trimester prenatal diagnosis of β-thalassemia. Prenatal diagnosis 2002; 22: 153–157.
Winichagoon P, Sriphanich R, Sae-Ngow B, Chowthaworm J, Tantisirin P, Kanokpongsakdi S, Fucharoen S, Wasi P. Applicatoin of automated HPLC in prenatal diagnosis of thalassemia. Lab Hematol 2002; 8: 29–35.
Colah R, Surve R, Nadkarni A, Gorakshakar A, Phanasgaonkar S, Satoskar P, Mohanty D. Prenatal diagnosis of sickle syndromes in India: dilemmas in counseling. Prenatal Diagnosis 2005; 25: 345–349.
Colosimo A, Guida V, De Luca A, Coppabianca MP, Biancoi I, Palka G, Dallapiccola B. Reliability of DHPLC in mutational screening of β globin (HBB) allele. Hum Mutat 2002; 19: 287–295.
Wu G, Hua I, Zhu J, Mo QH, Xu XM. Rapid accurate genotyping of β-thalassemia mutations using a novel multiplex primer extension/denaturing high performance liquid chromatography assay. Brit J Hematol 2003; 122: 311–316.
Guida V, Colosimo A, Fichera M, Lombardo T, Rigoli L, Dallapiccola B. Hematologic and molecular characterization of a Sicillian cohort of α thalassemia carriers. Haematologica 2006; 91: 409–410.
Colah RB, Gorakshakar AC. Thalassemias: Molecular genetics in antenatal diagnosis. In Lokeshwar MR, Marwaha RK, Shah M. eds. Recent advances in Pediatrics. New Delhi; Jaypee Brothers, 2000: 22–45.